

NCT00730301 Raw comparison:

Summary:
CHIA has 32 criteria while your personal folder has 34 criteria
Total found criteria: 32/32
Total not Found: 0/32
Total Extra: 2
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Patient diagnosed by HRCT Core Lab with eligible   │ Patient diagnosed by HRCT Core Lab with eligible   │
│ heterogeneous disease distribution and at least    │ heterogeneous disease distribution and at least    │
│ one complete oblique fissure                       │ one complete oblique fissure                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Age from 40 to 75 years                            │ Age from 40 to 75 years                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ BMI < 32 kg/m2                                     │ BMI \< 32 kg/m2                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ FEV1 < 40% of predicted value FEV1/FVC < 70%       │ FEV1 \< 40% of predicted value FEV1/FVC \< 70%     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ TLC > 120% predicted RV > 150% predicted           │ TLC \> 120% predicted RV \> 150% predicted         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Stable with < 20 mg prednisone (or equivalent) qd  │ Stable with \< 20 mg prednisone (or equivalent) qd │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ PaCO2 < 50mm Hg                                    │ PaCO2 \< 50mm Hg                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ PaO2 > 45 mm Hg on room air                        │ PaO2 \> 45 mm Hg on room air                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ 6-min walk of > 50m (without rehabilitation) or >  │ 6-min walk of \> 50m (without rehabilitation) or   │
│ 100m (with rehabilitation)                         │ \> 100m (with rehabilitation)                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Nonsmoking for 4 months prior to initial interview │ Nonsmoking for 4 months prior to initial interview │
│ and throughout screening                           │ and throughout screening                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ The patient agrees to all protocol required        │ The patient agrees to all protocol required        │
│ follow-up intervals                                │ follow-up intervals                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ The patient has no child bearing potential         │ The patient has no child bearing potential         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ The patient is willing and able to complete        │ The patient is willing and able to complete        │
│ protocol required baseline assessments and         │ protocol required baseline assessments and         │
│ procedures                                         │ procedures                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Prior endobronchial treatment for emphysema        │ Prior endobronchial treatment for emphysema        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pleural or interstitial disease that precludes     │ Pleural or interstitial disease that precludes     │
│ surgery                                            │ surgery                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Prior lung transplant LVRS median sternotomy       │ Prior lung transplant LVRS median sternotomy       │
│ bullectomy or lobectomy                            │ bullectomy or lobectomy                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Clinically significant bronchiectasis              │ Clinically significant bronchiectasis              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pulmonary nodule requiring surgery                 │ Pulmonary nodule requiring surgery                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of recurrent respiratory infections (> 3   │ History of recurrent respiratory infections (\> 3  │
│ hospitalization in the last year)                  │ hospitalization in the last year)                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Clinically significant (> 4 Tablespoons per day)   │ Clinically significant (\> 4 Tablespoons per day)  │
│ sputum production                                  │ sputum production                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Fever elevated white cell count or other evidence  │ Fever elevated white cell count or other evidence  │
│ of active infection                                │ of active infection                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Dysrhythmia that might pose a risk during exercise │ Dysrhythmia that might pose a risk during exercise │
│ or training                                        │ or training                                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Congestive heart failure within 6 mo and LVEF <    │ Congestive heart failure within 6 mo and LVEF \<   │
│ 45%                                                │ 45%                                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Evidence or history of Cor Pulmonale               │ Evidence or history of Cor Pulmonale               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Resting bradycardia (< 50 beats/min) frequent      │ Resting bradycardia (\< 50 beats/min) frequent     │
│ multifocal PVCs complex ventricular arrhythmia     │ multifocal PVCs complex ventricular arrhythmia     │
│ sustained SVT                                      │ sustained SVT                                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of exercise-related syncope                │ History of exercise-related syncope                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ MI within 6 mo and LVEF < 45%                      │ MI within 6 mo and LVEF \< 45%                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Evidence of systemic disease or neoplasia expected │ Evidence of systemic disease or neoplasia expected │
│ to compromise survival during 5-yr period          │ to compromise survival during 5-yr period          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Any disease or condition that interferes with      │ Any disease or condition that interferes with      │
│ completion of initial or follow-up assessments     │ completion of initial or follow-up assessments     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient is currently enrolled in another clinical  │ Patient is currently enrolled in another clinical  │
│ trial                                              │ trial                                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient is unable to complete 3 minutes of         │ Patient is unable to complete 3 minutes of         │
│ unloaded peddling on cycle ergometer               │ unloaded peddling on cycle ergometer               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Alpha-1-Antitrypsin Deficiency                     │ Alpha-1-Antitrypsin Deficiency                     │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have maximum age of 75 Years │
├───────────────────────────────────┤
│ Must have minimum age of 40 Years │
╘═══════════════════════════════════╛